Using data from 67 Ugandan human immunodeficiency virus (HIV) clinics (July 2019-January 2022), we report a 40% (1005/1662) reduction in the number of people with HIV presenting to care after August 2021 compared to prepandemic levels, with a greater proportion presenting with advanced HIV disease (20% vs 16% in the pre-coronavirus disease 2019 period).
Bibliographical noteFunding Information:
Financial support. R. R. and D. R. B. are supported by the National Institute of Allergy and Infectious Diseases (award numbers K23AI138851 and U01AI125003). C. P. S. is supported by the National Institutes of Health National Center for Advancing Translational Sciences (award numbers KL2TR002492 and UL1TR002494). P. S. is supported by a combined National Institute of Neurologic Disorders and Stroke and Fogarty International Center award (award number D43TW009345) via the Northern Pacific Global Health Fellows Program. J. E. is supported by a Wellcome Trust Clinical PhD Fellowship (grant number 203905/Z/16/Z). K. H. H. is supported by the University of Minnesota, Division of Biostatistics.
© 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
- advanced HIV disease
- opportunistic infections
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't